Vioxx & Roll: How Big Pharma Turned Heart Attacks Into a Business Model
Once upon a time in the magical land of Shareholder Value, a pharmaceutical giant named Merck gazed deep into the void of human suffering and asked the question all noble drugmakers must ask: “How can we make arthritis treatment more profitable than oil?”